INRS-Institut Armand-Frappier Revenue and Competitors
Estimated Revenue & Valuation
- INRS-Institut Armand-Frappier's estimated annual revenue is currently $21.9M per year.
- INRS-Institut Armand-Frappier's estimated revenue per employee is $112,200
Employee Data
- INRS-Institut Armand-Frappier has 195 Employees.
- INRS-Institut Armand-Frappier grew their employee count by -9% last year.
INRS-Institut Armand-Frappier's People
Name | Title | Email/Phone |
---|---|---|
1 | Research professionnal and lab manager | Reveal Email/Phone |
2 | Chercheur | Reveal Email/Phone |
3 | Agente de gestion financière | Reveal Email/Phone |
4 | Agent de recherche régulier coordonnateur de la plateforme de cytométrie et microscopie | Reveal Email/Phone |
5 | Epidemiologist | Reveal Email/Phone |
6 | Agente de Recherche | Reveal Email/Phone |
7 | Pofesseur | Reveal Email/Phone |
8 | Analyste sénior - Agents anabolisants - Laboratoire de contrôle du dopage | Reveal Email/Phone |
9 | Associate Professor | Reveal Email/Phone |
10 | assistance gestion de projets | Reveal Email/Phone |
INRS-Institut Armand-Frappier Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.3M | 111 | 8% | N/A | N/A |
#2 | $44.4M | 348 | 16% | N/A | N/A |
#3 | $11.3M | 111 | -10% | N/A | N/A |
#4 | $3.8M | 46 | 21% | N/A | N/A |
#5 | $8.4M | 82 | -2% | N/A | N/A |
#6 | $26M | 232 | 6% | N/A | N/A |
#7 | $14M | 137 | 1% | N/A | N/A |
#8 | $12.2M | 120 | 1% | N/A | N/A |
#9 | $6.7M | 73 | 6% | N/A | N/A |
#10 | $88.4M | 693 | -17% | N/A | N/A |
What Is INRS-Institut Armand-Frappier?
The INRS-Institut Armand-Frappier research centre, a component of the Institut national de la recherche scientifique (INRS), plays a vital role in research, training and technology transfers conducted in Quebec in the areas of human, animal and environmental health. INRS-Institut Armand-Frappier, which has approximately fifty faculty members, uses its extensive expertise in immunology and microbiology to determine the impact of infectious pathogens, cancer cells or organ transplants on the immune system, as well as to characterize various immune effector cells.\r\n\r\nThe INRS-Institut Armand-Frappier research centre is renowned both locally and internationally for its biomedical expertise and represents a vital crossroad for health-related research in Quebec. Members of the Centre's team have exceptional, even unique, analytical capabilities in the fields of chemistry, microbiology and immunology, genomics and proteomics as well as molecular and cellular biology. The established credibility of the Centre's doping control laboratory played a key role in the World Anti-Doping Agency's decision to establish its headquarters in Montreal. In addition, on the strength of its expertise in immunity, infectious diseases and cancer as well as its solid experience in using animal models, the National Centre for Experimental Biology - a major project funded by the Canadian Foundation for Innovation and the Quebec government - was set up on the City of Laval campus. The INRS-Institut Armand-Frappier research centre is also one of the cornerstones in the development of the City of Biotechnology and Human Health of Metropolitan Montreal, an initiative promoted by INRS.
keywords:N/AN/A
Total Funding
195
Number of Employees
$21.9M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
INRS-Institut Armand-Frappier News
Institut national de la recherche scientifique - INRS ... Urbanisation Culture Société, and Armand-Frappier Santé Biotechnologie. The INRS...
INRS researchers and international partners have succeeded in looking at spin ... Culture Société, and Armand-Frappier Santé Biotechnologie.
QUÉBEC, April 8, 2022 /CNW Telbec/ - INRS (Institut national de la recherche ... Culture Société, and Armand-Frappier Santé Biotechnologie.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $71.5M | 197 | 3% | N/A |
#2 | $81.5M | 210 | 7% | N/A |
#3 | $59.6M | 221 | 26% | N/A |
#4 | $65.9M | 222 | 7% | N/A |
#5 | $81.7M | 225 | 4% | N/A |